(Q91567360)

English

Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report

scientific article published on 02 April 2020

Statements

Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit